ImmuDyne Announces Appointment of Amilya Antonetti as Chief Digital Strategist
December 05 2017 - 8:00AM
ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader
in the development and online marketing of OTC health and wellness
products addressing large unmet needs, today announces that Amilya
Antonetti has accepted a position as an advisor to the company.
Ms. Antonetti is a prominent television host and human behavior
expert. A former contributor to Fox News and CNBC, she regularly
appears on many of America’s largest television talk shows, cable
news networks and national talk radio. She brings her 30 plus years
of brand building and expertise as a digital strategist to the
Immudyne team. Additionally, Ms. Antonetti has deep
experience in online direct marketing and influencer marketing, two
very important areas of focus for ImmuDyne in 2018.
Ms. Antonetti is particularly passionate about the inevitable
growth opportunity for e-commerce and especially companies like
Immudyne that own and operate online brands that are superior to
what is found in traditional brick and mortar retailers.
“In the U.S., e-commerce is growing approximately 10% per year,
representing approximately $400B in overall sales revenue,” stated
Ms. Antonetti. “In 2017, Credit Suisse forecasts that in the U.S.
8,640 brick-and-mortar store locations will shut their doors.
E-tailers like ImmuDyne, as opposed to traditional retailers, can
quickly launch proprietary brands that can be marketed directly to
the global consumer via platforms like Facebook, Google and
Amazon. It’s an extremely targeted, scalable and efficient
business model that eliminates many of the logistical and
operational expenses typically found in traditional brick and
mortar retailers. Direct to consumer can also facilitate enhanced
consumer experience as we use today's technology to better learn
and serve our customers.”
“ImmuDyne is thrilled to have someone with Ms. Antonetti’s
experience and relationships on the team,” stated Stefan Galluppi,
CMO and Director of Immudyne. “We believe she will add a tremendous
amount of value as we continue to grow our portfolio of online
brands in 2018 and beyond.”
About lmmuDyne
lmmuDyne, Inc. (the "Company") is a health and wellness company
that develops, manufactures, and markets innovative consumer
products in the health and wellness sector. ImmuDyne
manufactures and markets a proprietary and patent protected Yeast
Beta Glucan ingredient that has been shown in thousands of clinical
studies to support and regulate the human immune system. It
has broad applications in skincare and as an immune support
supplement. Immudyne PR, a majority owned subsidiary of
ImmuDyne, Inc., is the digital marketing arm of Immudyne and is
currently focused on marketing products for thicker and fuller hair
(Shapiro MD) and a skincare line containing Immudyne’s proprietary
Yeast Beta Glucan ingredient (Inate MD). All of lmmuDyne's
intellectual property is protected by patents and/or trade secrets.
Additional information can be found on the web at
www.immudyne.com.
Forward-Looking Statements
Cautionary language regarding Forward-Looking Statements Safe
Harbor Act Disclaimer: Forward-looking statements in this release
are made pursuant to the Safe Harbor Provisions of the Private
Securities Litigation Reform Act of 1995. Certain statements in
this press release, including projections with respect to
lmmuDyne's results of operations, may contain words such as
"anticipates," "believes," "could," "estimates," "expects,"
"intends," "may," "projects," "plans," "targets" and other
similar language and are considered forward-looking statements.
These statements are based on management's current expectations,
estimates, and forecasts. These forward-looking statements are
subject to important assumptions, risks and uncertainties, which
are difficult to predict and therefore the actual results may be
materially different from those discussed.
Investor Relations Contact:
Bernard Girma +1-949-215-7754